AMO to be acquired by Abbott

Article

Advanced Medical Optics (AMO) has been acquired by Abbott, a global pharmaceutical and medical device company, the companies have announced in a statement.

Advanced Medical Optics (AMO) is to be acquired by Abbott, a global pharmaceutical and medical device company, the companies have announced in a statement. The $2.8 billion acquisition is expected by both companies to be completed in the first quarter of this year.

Abbott, one of the world's largest healthcare companies, currently has no presence in the ophthalmic market, although it markets its products in 130 countries globally. The acquisition will allow Abbott to take advantage of AMO's leading position in the LASIK surgical devices market, and to capitalize on the company's top-three position in the cataract surgical devices and contact lens care products markets.

Abbott will acquire AMO at $22 per share in a cash transaction, commencing on January 26, 2009. Jim Mazzo, the current chairman and chief executive officer of AMO will remain as AMO's president when the acquisition is complete.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.